Risk Factors Associated With Non-Respondence to Methotrexate in Rheumatoid Arthritis Patients.

Introduction: Oral methotrexate (MTX) is the first-line therapy for patients with rheumatoid arthritis (RA). However, not all RA patients respond to MTX. In this study, we will determine the risk factors associated with MTX failure.